Concepedia

Deborah L. Higgins

DL

Statistics

Publications

24

Citations

2.1K

H-Index

20

Active since

1981

Affiliations

Theravance Biopharma (United States)(Current)

University of Michigan

LightSpin Technologies (United States)

Mayo Clinic

Deborah L. Higgins is an author at Theravance Biopharma (United States) specializing in medicine, natural sciences, and biochemistry.

Top concepts

Publications per year

1981–2012

24

Publications

24

Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant <i>Staphylococcus aureus</i>

Deborah L. Higgins, Ray Chang, Dmitri Debabov et al. · Antimicrobial Agents and Chemotherapy · 2005 · 426 citations · Full text

, , +22

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.

Raymond R. Schleef, Deborah L. Higgins, E Pillemer et al. · Journal of Clinical Investigation · 1989 · 213 citations · Full text

Predicting ligand binding to proteins by affinity fingerprinting

Lawrence M. Kauvar, Deborah L. Higgins, Hugo O. Villar et al. · Chemistry & Biology · 1995 · 210 citations · Full text

, , +8

The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles.

Deborah L. Higgins, Kenneth G. Mann · Journal of Biological Chemistry · 1983 · 171 citations · Full text

Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.

Deborah L. Higgins, Sidney D. Lewis, Jules A. Shafer · Journal of Biological Chemistry · 1983 · 153 citations · Full text

1–5 of 24